APLM
Apollomics Inc. Class A Ordinary Shares
$6.920+-0.000 (-0.000%)
Echtzeitkurs
Kursdiagramm
Loading Chart...
Schlüsselkennzahlen
Marktkennzahlen
Eröffnung
$6.920
Hoch
$6.920
Tief
$6.920
Volumen
0.00M
Unternehmensfundamentaldaten
Handelsstatistiken
Ähnliche Nachrichten
GlobeNewswire
Apollomics Reports Full Year 2024 Financial Results and Highlights Clinical Updates and Business Progress
Strategic collaboration with LaunXP for the development of vebreltinib in combination with an EGFR inhibitor ("EGFRi") to bring in $10 million upfront payment and expand dataset to combination therapyNew interim data for
Mehr anzeigen
GlobeNewswire
Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib
LaunXP receives exclusive development and commercialization rights for vebreltinib in combination with an EGFR inhibitor in Asia (excluding mainland China, Hong Kong and Macau) for the treatment of non-small cell lung
Mehr anzeigen
Ähnliche Aktien
Bleiben Sie auf dem Laufenden
Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.